Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD

Abstract

Reassuringly, half of the IBD patients on the TNFα-blocking maintenance therapy achieved deep remission. The majority of patients in deep remission also achieved histological remission.